Replies to post #221492 on Biotech Values

[oc631]

Interesting quote, pulled off twitter


Narasimhan: "We are on our journey to focus our company on being a medicines company," including three advanced therapy platforms: cell therapy, gene therapy, and radiopharmaceuticals."


Credit: @Jessicaemerrill

[north40000]

The comment and content of this document may offer one, or partial, explanation for NVS move:

https://investor.amarincorp.com/static-files/348586ab-c69f-4488-8cd6-4a24991214b7